Update on the advances and challenges in bioequivalence testing methods for complex topical generic products
Most of the government regulatory agencies, including the United States Food and Drug Administration and the European Medicine Agency, demand that the generic complex topical products prove pharmaceutical and bioequivalence. The evaluation of bioequivalence for complex topical dermatological formula...
Saved in:
Main Authors: | Nedaa Alomari (Author), Waleed Alhussaini (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generic Drug Product Development Bioequivalence Issues
by: Iain J. McGilveray
Published: (2008) -
Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
by: Muhammad M. Hammami, et al.
Published: (2017) -
Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%
by: Eleftheria Tsakalozou, et al.
Published: (2021) -
Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products
by: Ana Sofia Agonia, et al.
Published: (2022) -
BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023)